Mechanism of Arkeshwara rasa to combat hepatocellular carcinoma
DOI:
https://doi.org/10.47552/ijam.v15iS1.5555Keywords:
HCC, AR, Rutin, Hesperidine, Kaempferol, Quercetin, MTT Assay, AO AssayAbstract
Background: Immunomodulatory treatments along with systemic and loco-regional methodology of treatment approach have reduced the incidence of Hepatocellular carcinoma (HCC) in recent observations. The phytomolecular applications have been seen to reverse the hepatic fibrosis aiding in regeneration of hepatocytes. The cytotoxicity of Arkeshwara rasa (AR) was investigated on HCC cell lines to observe the general signs of apoptosis. Methodology: The MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay and Ethidium Bromide/Acridine orange Assay (EtBr/AO) were subjected on AR to know the cytotoxicity and the apoptotic results. Results: The IC50 of 37.14 μg/ml was exhibited by AR against Huh 7 cell lines and the (EtBr/ AO) Assay demonstrated the early and late apoptotic features in comparison with Untreated and Doxorubicin standard drug. Conclusion: AR on the basis of present evaluation against HCC cell lines and previous results on various other cell lines might be able to check the pathogenesis progression of HCC cells initiating the apoptotic features or reviving the vulnerable cell from further damage because of the phyto-constituents or mineral inclusions. These preliminary observations have to be again revalidated with reverse transcription, cDNA synthesis, western blotting, cell cycle analysis, etc.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.